Voltage-gated sodium channels: A prominent target of marine toxins

dc.contributor.authorMackieh, Rawan
dc.contributor.authorAbou-Nader, Rita
dc.contributor.authorWehbe, Rim
dc.contributor.authorMattei, César
dc.contributor.authorLegros, Christian
dc.contributor.authorFajloun, Ziad
dc.contributor.authorSabatier, Jean-Marc Marc
dc.contributor.departmentDepartment of Biology
dc.contributor.facultyFaculty of Arts and Sciences (FAS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:21:06Z
dc.date.available2025-01-24T11:21:06Z
dc.date.issued2021
dc.description.abstractVoltage-gated sodium channels (VGSCs) are considered to be one of the most important ion channels given their remarkable physiological role. VGSCs constitute a family of large transmembrane proteins that allow transmission, generation, and propagation of action potentials. This occurs by conducting Na+ ions through the membrane, supporting cell excitability and communication signals in various systems. As a result, a wide range of coordination and physiological functions, from locomotion to cognition, can be accomplished. Drugs that target and alter the molecular mechanism of VGSCs’ function have highly contributed to the discovery and perception of the function and the structure of this channel. Among those drugs are various marine toxins produced by harmful microorganisms or venomous animals. These toxins have played a key role in understanding the mode of action of VGSCs and in mapping their various allosteric binding sites. Furthermore, marine toxins appear to be an emerging source of therapeutic tools that can relieve pain or treat VGSC-related human channelopathies. Several studies documented the effect of marine toxins on VGSCs as well as their pharmaceutical applications, but none of them underlined the principal marine toxins and their effect on VGSCs. Therefore, this review aims to highlight the neurotoxins produced by marine animals such as pufferfish, shellfish, sea anemone, and cone snail that are active on VGSCs and discuss their pharmaceutical values. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
dc.identifier.doihttps://doi.org/10.3390/md19100562
dc.identifier.eid2-s2.0-85117064053
dc.identifier.pmid34677461
dc.identifier.urihttp://hdl.handle.net/10938/25207
dc.language.isoen
dc.publisherMDPI
dc.relation.ispartofMarine Drugs
dc.sourceScopus
dc.subjectCone snail
dc.subjectMarine toxins
dc.subjectNeurotoxins
dc.subjectPufferfish
dc.subjectSea anemone
dc.subjectShellfish
dc.subjectVgscs
dc.subjectAnalgesics
dc.subjectAnimals
dc.subjectBiological products
dc.subjectHumans
dc.subjectPain
dc.subjectSea anemones
dc.subjectSnails
dc.subjectTetraodontiformes
dc.subjectVoltage-gated sodium channels
dc.subjectAe i
dc.subjectAetx i
dc.subjectAft i
dc.subjectAft ii
dc.subjectAntillatoxin
dc.subjectApa
dc.subjectApb
dc.subjectAtx ii
dc.subjectBc ii
dc.subjectBc iii
dc.subjectBrevetoxin
dc.subjectCalitoxin i
dc.subjectCiguatoxin
dc.subjectCp i
dc.subjectCp ii
dc.subjectCrossbynols a
dc.subjectHalcurin
dc.subjectHk2
dc.subjectHoiamides a
dc.subjectHoiamides b
dc.subjectJamaicamides a
dc.subjectJamaicamides b
dc.subjectJamaicamides c
dc.subjectKalkitoxin
dc.subjectMarine toxin
dc.subjectPalmyramide a
dc.subjectPalmyrolide a
dc.subjectRc i
dc.subjectSaxitoxin
dc.subjectTetrodotoxin
dc.subjectUnclassified drug
dc.subjectVoltage gated sodium channel
dc.subjectAnalgesic agent
dc.subjectBiological product
dc.subjectAnalgesia
dc.subjectMarine species
dc.subjectNonhuman
dc.subjectPoisonous animal
dc.subjectProtein structure
dc.subjectPuffer fish
dc.subjectReview
dc.subjectToxin analysis
dc.subjectAnimal
dc.subjectDrug effect
dc.subjectHuman
dc.subjectSnail
dc.titleVoltage-gated sodium channels: A prominent target of marine toxins
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021-5834.pdf
Size:
1.63 MB
Format:
Adobe Portable Document Format